Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

NCT: NCT04183218 · COMPLETED

NCT IDNCT04183218
StatusCOMPLETED
Start Date2019-09-23
Completion2024-05-02

Brief Summary

This trial studies cardiac changes after radiation or chemo-radiation for the treatment of lung or esophageal cancer that has not spread to other places in the body (non-metastatic) or has not come back (non-recurrent). Continuous cardiac monitoring with an implanted device may help to identify cardiac changes that would remain unnoticed, and facilitate the treatment of these early cardiac changes as part of standard care.

Frequently Asked Questions

What is Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes?

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes is a clinical trial registered under NCT04183218. Current status: COMPLETED.

What is the status of NCT04183218?

The current status of NCT04183218 (Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes) is: COMPLETED.

When did Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes start?

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes started on 2019-09-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.